Physician profile
Aria C Murphy
NPI 1023314382
$1,965.82
in general payments reported to CMS, 2019-2025
21 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2020: $146 · 2021: $277 · 2022: $353 · 2023: $505 · 2024: $423 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,048.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,047.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $428.78 | 2020-2023 | |
| Sun Pharmaceutical Industries INC. | $310.23 | 2019-2025 | Cequa |
| Horizon Therapeutics Plc | $161.22 | 2020-2023 | Tepezza |
| Bausch & Lomb Americas INC. | $126.80 | 2023-2025 | Xiidra, Vyzulta, Miebo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $114.20 | 2019-2020 | |
| Kala Pharmaceuticals, INC. | $102.75 | 2021-2022 | |
| Johnson & Johnson Vision Care, INC. | $99.03 | 2024 | Acuvue |
| Abbvie INC. | $97.67 | 2023 | |
| Amgen INC. | $80.79 | 2024 | Tepezza |
| Tarsus Pharmaceuticals, INC. | $77.60 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $55.90 | 2022-2023 | Tyrvaya |
| Alcon Vision LLC | $55.46 | 2022-2024 | Hydrus Microstent |
| Harrow Eye, LLC | $43.11 | 2024-2025 | Vevye |
| Mallinckrodt Hospital Products INC. | $42.53 | 2022-2024 | Acthar |
| Coopervision INC. | $42.51 | 2019-2023 | Misight Contact Lens |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $36.51 | 2022 | |
| Eyevance Pharmaceuticals LLC | $31.13 | 2021 | |
| Aerie Pharmaceuticals, INC. | $17.60 | 2019 | |
| Biotissue Holdings INC. | $16.03 | 2020 | |
| Shire North American Group INC | $14.13 | 2019 | |
| Abb Con-Cise Optical Group LLC | $11.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aria Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.